Altered Young Adult: Seen in the ED
Fever and confusion bring the young man in his twenties to the ED; roommates relate he's been weak and flu-like for 5 days. What's your diagnosis?
COPD Management & Pharmacotherapy: A GOLD Guideline Topline
Get GOLD Report updates at-a-glance on initiating pharmacotherapy, avoiding exacerbations, treating dyspnea, how to approach using ICS, plus other topics.
Cannabis Use and Risk of Prevalent Asthma: Daily Dose
Your daily dose of the clinical news you may have missed.
13 Drugs Approved for Primary Care in 2023
Get a quick look at 13 of the many FDA-approved drugs in 2023 for conditions commonly seen in primary care.
GSK RSV Vaccine Arexvy Under FDA Priority Review for Prevention of RSV in High-Risk Adults Aged 50 to 59 Years
Approval of the application would extend the current Arexvy indication for prevention of RSV in adults aged 60 years and older; a June 2024 PDUFA date is set.
Depression, IBD Combo Raises Risk of Hospital Readmission, Mortality: Daily Dose
Novel Weight Loss Entrant from Amgen Challenges Duration of Effect and Dosing with Wegovy, Zepbound
Amgen's investigational maridebart cafraglutide in a phase 1 trial led to durable weight reduction following less frequent and lower doses, the company said.
Younger Infants and Children Born Prematurely at Highest Risk for RSV Hospitalization, According to New Study
Results showed nearly one-third of hospitalizations for acute respiratory illness among children aged <5 years were associated with RSV.
Risk for a Suicide Attempt Found 8-Fold Greater in Women with PCOS
Among women with PCOS, the risk for a suicide attempt was highest (by a factor of 9) among young adults aged 20 to 40 years, followed by adolescents.
Survey Data Underscores Education Gap in Ulcerative Colitis for Primary Care Clinicians: Daily Dose
Influenza Vaccines: 4 Questions on What to Order, Which to Use
Influenza continues to rage in some parts of the US; try these 4 quick questions on vaccines you may or may not have on hand.
The 2024 COPD GOLD Report: A Guideline Topline, Part 1
Updates in the Global Initiative for Obstructive Lung Disease report include using spirometry values in diagnosis and optimizing inhaled pharmacotherapy.
Noninvasive Tests May be Poor Predictor of Liver Fibrosis, Especially Among Black Adults
Using FIB-4 index first to screen for cirrhosis may lead to clinicians missing 48% of cases, according to a recent study.
Vagus Nerve Stimulation in Narcolepsy: Daily Dose
Screenings for Cancer, Other Preventive Visits Continue to Lag Post-Pandemic
Preventive health screenings have yet to rebound to pre-COVID-19 levels and Asian adults appear to have fallen behind more than other racial/ethnic groups, a new study finds.
Tirzepatide Associated with "Impressive" BP Reduction in Individuals with Obesity
Mean placebo-adjusted SBP change from baseline at 36 weeks was 8.6 mm Hg in adults with obesity, according to authors of the SURMOUNT-1 ABPM substudy.
CDC: Gonorrhea Cases Declined for First Time in Decade, but Syphilis Keeps Climbing
Reported cases of chlamydia, syphilis, and gonorrhea in the US surpassed 2.5 million for the third time in 5 years, according to CDC.
HHS Broadens Access to Medications, Treatment for Opioid Use Disorder
Access to methadone and buprenorphine treatment may be easier and incentive to continue treatment could start at home, using telehealth, according to HHS.
Migraine-Related Stigma Impacts Quality of Life: Daily Dose
Combination Albuterol/Budesonide Rescue Medication for Adults with Asthma Now Available
The combination SABA/ICS inhaler is the first of its kind and treats both acute bronchoconstriction and the inflammation that drives asthma and disease exacerbation.
